Mouth Neoplasms Clinical Trials

Active, not recruiting

Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls

NCT00867464

Conditions: Anal Carcinoma, Anus Diseases, Anus Neoplasms, +41 more
Locations: Agencia Costarricense de Investigaciones Biomédicas (ACIB) Liberia, Guanacaste Province, Costa Rica

View Trial Details

Active, not recruiting

Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer

NCT04576091

Conditions: Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +52 more
Locations: Los Angeles General Medical Center Los Angeles, California, United States

USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

Northwestern University Chicago, Illinois, United States

Montefiore Medical Center-Einstein Campus The Bronx, New York, United States

View Trial Details

Active, not recruiting

Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers

NCT05063552

Conditions: Carcinoma, Carcinoma, Squamous Cell, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +45 more
Locations: University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

Epic Care-Dublin Dublin, California, United States

Epic Care Partners in Cancer Care Emeryville, California, United States

UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States

View all 172 locations

View Trial Details

Active, not recruiting

Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study

NCT05075980

Conditions: Cutaneous Squamous Cell Carcinoma of the Head and Neck, Head and Neck Carcinoma, Head and Neck Carcinoma of Unknown Primary, +36 more
Locations: Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States

Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

Mayo Clinic Health System in Albert Lea Albert Lea, Minnesota, United States

View Trial Details

Active, not recruiting

Oral Mucositis Management in Patients Receiving Radiation for Head and Neck Cancer: An Evaluation of a Barrier Based Treatment

NCT07697287

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +20 more
Locations: Juravinski Cancer Centre Hamilton, Ontario, Canada

View Trial Details

Active, not recruiting

RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer

NCT05966194

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +14 more
Locations: Banner MD Anderson Cancer Center Gilbert, Arizona, United States

The University of Arizona Cancer Center Tucson, Arizona, United States

Miami Cancer Institute Miami, Florida, United States

Northwestern University Feinberg School of Medicine Chicago, Illinois, United States

View all 14 locations

View Trial Details

Active, not recruiting

Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion

NCT02581137

Conditions: Erythroplakia, Erythroplasia, Head and Neck Neoplasms, +14 more
Locations: UC San Diego Medical Center - Hillcrest San Diego, California, United States

University of Minnesota/Masonic Cancer Center Minneapolis, Minnesota, United States

BC Cancer Research Centre Vancouver, British Columbia, Canada

University of British Columbia Hospital Vancouver, British Columbia, Canada

View Trial Details

Active, not recruiting

Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

NCT04862650

Conditions: Carcinoma, Carcinoma, Squamous Cell, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +43 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Active, not recruiting

Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN

NCT03529422

Conditions: Digestive Organs--Diseases, Head and Neck Neoplasms, Laryngeal Diseases, +11 more
Locations: University Of Alabama At Birmingham Birmingham, Alabama, United States

UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States

Medical University of South Carolina - Hollings Cancer Center Charleston, South Carolina, United States

View Trial Details

Active, not recruiting

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

NCT02834013

Conditions: Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States

Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States

Anchorage Radiation Therapy Center Anchorage, Alaska, United States

View all 1007 locations

View Trial Details

Mouth Neoplasms

Mouth Neoplasms trial results

Related conditions